Notices from March 25, 2020 to April 01, 2020

ARTS / HUMANITIES / INTERNATIONAL

Funding Opportunities

• Annual Program Statement
• Statements of Interest for Human Rights, Accountability, and Access to Information in the Democratic People’s Republic of Korea (DPRK or North Korea) Round 3
• YouthPower 2 (YP2) Annual Program Statement (APS)

EDUCATION / ECONOMIC AND COMMUNITY DEVELOPMENT

Funding Opportunities

• BLM-CO Expanding Recreational Opportunities on Colorado’s Public
• Enterprising Women of Color
• EONS 2020: Appendix I MUREP Space Technology Artemis Research
• Fiscal Year (FY) 2020 Targeted Violence and Terrorism Prevention (TVTP) Program
• Food and Agriculture Service Learning Program (FASLP)
• Interdisciplinary Preparation in Special Education Early Intervention and Related Services for Personnel Serving Children with Disabilities who have High-Intensity Needs, CFDA Number 84.325K: Focus Area B
• Rehabilitation Services Administration (RSA): Rehabilitation Long-Term Training program–Vocational Rehabilitation Counseling CFDA Number 84.129B

Meetings

• Open Meeting of the Taxpayer Advocacy Panel’s Toll-Free Phone Line Project Committee

HEALTH

Funding Opportunities

·         Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

·         BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs – eTeamBCP (U01 Clinical Trials Optional)

·         Child Health Research Career Development Award (CHRCDA) Program (K12 Clinical Trial Not Allowed)

·         DoD Neurofibromatosis, Clinical Trial Award

·         DoD Neurofibromatosis, Early Investigator Research Award

·         DoD Neurofibromatosis, Exploration- Hypothesis Development Award

·         DoD Neurofibromatosis, New Investigator Award

·         DoD Orthotics and Prosthetics Outcomes, Clinical Research Award

·         DoD Orthotics and Prosthetics Outcomes, Clinical Trial Award

·         DoD Tuberous Sclerosis Complex, Exploration- Hypothesis Development Award

·         Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

·         Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

·         MTEC-20-09-COVID-19_Treatment_MIDRP “Development of Treatments for COVID-19”

·         NIH Science Education Partnership Award (SEPA) (R25 – Clinical Trial Not Allowed)

·         Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional)

·         Nurse Education, Practice, Quality and Retention (NEPQR) Simulation Education Training (SET) Program

·         Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)

·         Strengthening Aging Services for Minority Populations Through Technical Assistance, Resource Development, and Program Coordination

·         Supporting Tribal Public Health Capacity in Coronavirus Preparedness and Response Department of Health and Human Services

·         Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional)

·         Treatment, Recovery, and Workforce Support Grants

·         Tuberculosis Research Units (U19 Clinical Trial Optional)

·         UNITED STATES MILITARY ACADEMY Broad Agency Announcement

SCIENCE / TECHNOLOGY / ENGINEERING / MATH

Funding Opportunities

·         ED.gov Redesign Challenge

·         EONS 2020: Appendix J NASA MUREP INCLUDES PLANNING GRANT

·         HERO Appendix F: NASA Human Research Program Omnibus Opportunity and Appendix E: Topics in Human Factors and Behavioral Performance

·         Information Technology Laboratory (ITL) Broad Agency Announcement (BAA)

·         NAWCA 2021 Mexico Standard Grant

·         NAWCA 2021-2 Canada Grants

·         Ocean of Things Phase 2, Technical Area 2

Meetings

·         Notification of a Public Meeting of the Science Advisory Board Economic Guidelines Review Panel

This information was compiled and edited by Ken McDonald with assistance from the GRC Staff.